肝7/8段0-A期肝细胞癌切除:开腹、腹腔镜与机器人倾向匹配分析
该回顾性研究纳入2017年7月至2023年7月在广西医科大学第一附属医院因BCLC 0-A期肝细胞癌行S7/8段切除的401例患者,经倾向评分匹配后比较开腹、腹腔镜与机器人肝切除的结局。机器人组失血量最少(100 vs 215 vs 300 mL,P<0.001),中转率低于腹腔镜组(1.3% vs 13.5%,P=0.003),微创组住院更短、手术并发症更少,三组无病生存与总生存无显著差异。
要点
- 机器人S7/8段切除失血量显著少于开腹和腹腔镜(100 vs 215 vs 300 mL,P<0.001)。
- 机器人组中转率显著低于腹腔镜组(1.3% vs 13.5%,P=0.003)。
- 微创组住院更短、手术并发症更少,三组生存无显著差异。
核心结论
- 对于BCLC 0-A期S7/8段肝细胞癌,机器人肝切除在短期结局上优于开腹和腹腔镜,在生存结局上不劣于两者。
研究设计与样本
- 回顾性收集2017年7月至2023年7月广西医科大学第一附属医院因BCLC 0-A期HCC行S7/8段切除的401例患者临床数据。
- 采用倾向评分匹配(PSM)以ASA、肿瘤大小、BMI、AFP、肿瘤位置、年龄、肿瘤数目、血小板和病毒性肝炎为匹配变量。
- 匹配后纳入开腹61例(28.6%)、腹腔镜74例(34.8%)、机器人78例(36.6%)。
主要发现
- 机器人组失血量最少(开腹300 mL vs 腹腔镜215 mL vs 机器人100 mL,P<0.001)。
- 机器人组中转率显著低于腹腔镜组(1.3% vs 13.5%,P=0.003)。
- 微创组(机器人+腹腔镜)术后住院更短(开腹8天 vs 腹腔镜6天 vs 机器人6天,P<0.001)。
- 微创组手术并发症率更低(开腹37.7% vs 腹腔镜20.3% vs 机器人11.5%)。
- 三组无病生存率与总生存率无统计学显著差异。
临床怎么用
- 在具备机器人系统的中心,对BCLC 0-A期S7/8段HCC可优先考虑机器人肝切除以降低失血和中转风险。
- 微创方式(机器人或腹腔镜)有助于缩短术后住院并减少手术并发症。
- 生存获益方面三种术式无显著差异,术式选择应结合中心技术条件与患者个体情况。
局限性
- 回顾性单中心研究,存在选择偏倚可能,虽经PSM但仍可能有未测量混杂。
- 匹配后各组样本量有限(开腹61例、腹腔镜74例、机器人78例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Both laparoscopic hepatectomy (LH) and robotic hepatectomy (RH) have been performed for tumors in nearly all liver segments. However, few studies have compared the outcomes of patients who underwent open hepatectomy (OH), LH and RH for the treatment of Barcelona Clinic Liver Cancer (BCLC) stage 0-A HCC in S7/8. METHODS: The clinical data of patients who underwent S7/8 resection for the treatment of BCLC stage 0-A HCC in the First Affiliated Hospital of Guangxi Medical University from July 2017 to July 2023 were retrospectively collected. To minimize selection bias, propensity score matching (PSM) analysis was performed using American Society of Anesthesiology (ASA), tumor size, body mass index (BMI), alpha-fetoprotein (AFP), tumor location, age, number of tumors, platelet (PLT), and Viral hepatitis. RESULTS: A total of 401 patients met the study criteria. After PSM, 61 OH (28.6%), 74 LH (34.8%), and 78 RH (36.6%) were included. RH group had the least blood loss among the three groups (OH, 300 vs. LH, 215 vs. RH, 100 mL, P < 0.001). Conversion rate was significantly lower in RH group compared to LH group [LH, 10 (13.5%) vs. RH, 1 (1.3%), P = 0.003]. Although minimally invasive group (RH + LH) took slightly longer operative time (OH, 233 vs. LH, 255.5 vs. RH, 257 min, P = 0.068), there was no statistical difference. The minimally invasive group had fewer postoperative hospital stay (OH, 8 vs. LH, 6 vs. RH, 6 days, P < 0.001). The minimally invasive group had lower rates of surgical complications (OH, 37.7% vs. LH, 20.3% vs. RH, 11.5%). However, there were no statistically significant variations observed in the disease-free survival or overall survival rates among the three groups. CONCLUSIONS: RH showed advantage over the OH and LH in short-term outcomes, and non-inferiority in survival outcomes for the treatment of BCLC stage 0-A HCC patients.
引用
- Wang Y, Lu S, Tan X, et al. Liver resection in stage 0-A HCC in segments 7/8: a propensity-matched analysis comparing open, laparoscopic, and robotic approach. Surg Endosc. 2025. PMID: 39849072. doi:10.1007/s00464-024-11521-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。